Ekf Diagnostics Share Discussion Threads

[tongosti] 08/12/2020 14:20

The next update better beat the sky high street's expectations as if it doesn't ...

[jacks13] 08/12/2020 09:17

' ...the PrimeStore® MTM sample collection device supplied by EKF Diagnostic Holdings plc (AIM: EKF)'

Primestore being supplied to MyHealthChecked PLC

[wan] 08/12/2020 07:34

One assumes that the commencement of mass-manufacturing in the US has now resulted in availability and roll-out here too -


EKF introduces accurate quantitative COVID-19 antibody test kit

Cardiff, UK – 7 December 2020 – EKF Diagnostics, the global in vitro diagnostics company, announces that it has introduced one of the first tests to precisely measure levels of COVID-19 neutralizing antibodies in individuals. Unlike other antibody tests, the Kantaro COVID-SeroKlir SARS-CoV-2 IgG antibody test kit determines both the presence and specific quantities of human IgG antibodies to the SARS-CoV-2 virus. This enables a broad range of COVID-19 applications, such as delivering vital knowledge for advancing the understanding of protective immunity, assessing vaccine response and accelerating therapeutic treatments.

The high performance quantitative COVID-SeroKlir kit has received FDA Emergency Use Authorization (EUA) and is CE marked. It has demonstrated 98.8% sensitivity and 99.6% specificity for detecting SARS-CoV-2 specific IgG antibodies against two SARS-CoV-2 virus antigens, the full-length spike protein and its receptor-binding domain (RBD). This confirmed accuracy means false positives and false negatives are minimized.

The best-in-class serologic COVID-19 assay is based on technology developed by clinicians at the Icahn School of Medicine at Mount Sinai Health System in New York in partnership with RenalytixAI, a spinout company from EKF Diagnostics. Here, COVID-SeroKlir has been validated on a highly diverse cohort of more than 75,000 patients, including over 30,000 who were diagnosed with COVID-19; this is more than any other COVID-19 test. In addition, the test has been independently verified by peer reviewed journals, including Nature and Science [1, 2], as well as the U.S. National Institutes of Health (NIH).

The Mount Sinai study also demonstrated that over 90% of infected individuals with mild-to-moderate COVID-19 experience robust IgG antibody responses against the viral spike protein [2]. In addition, these COVID-19 neutralizing antibody levels were confirmed to be relatively stable during the first five months after infection.

Explaining the value of knowing the precise levels of SARS-CoV-2 IgG antibodies, Julian Baines, CEO of EKF, said, “Quantitative IgG antibody testing can provide important support for determining public health strategies, informing healthcare decision making, and verifying the effectiveness of vaccines as they become available. It is also an essential component of a general health check to determine past COVID-19 infections. This is because COVID-19 has been linked with an increased risk of potentially life-threatening complications, including lung, kidney, and cardiovascular disease.”

EKF holds exclusive rights to market and distribute the Kantaro COVID-SeroKlir kit in the UK and Germany, and non-exclusive rights in the rest of Europe. Julian Baines added, “With the capacity to manufacture up to 10 million tests per month, EKF is well placed to drive rapid availability of COVID-SeroKlir kits to a broad range of laboratories for immediate operation without needing specialized testing equipment.”

Full release -

[rivaldo] 07/12/2020 07:17

Cheers MalcolmMM - should provide a nice boost this week.

[malcolmmm] 06/12/2020 10:59

Techinvest says Buy

[wan] 06/12/2020 07:32

ESG investing is becoming increasingly popular, with investors pouring money into ESG funds. So, I was interested to note in the IC that EKF feature in the Top ESG Fund Managers' Favourite UK Shares as of 02/12/2020 FUND BEST IDEAS: UK SUSTAINABLE -


Only one fund is registered (over half of the list has one ESG fund invested) and is based on a funds top 5 holdings (source: Morningstar), but given the increasing interest in the ESG sector, that leaves room for further interest/investment -

The Big Theme December 3 2020

The best regional ESG funds

By Dave Baxter

The explosion of the ESG industry means investors have more fund choices

Regional equity fund options are increasing

You must first decide what type of ESG approach you want to take

Funds that invest according to environmental, social and governance (ESG) principles have proved their worth, with a commendable performance during the sell-off earlier this year. They are also becoming increasingly popular with investors and appear to have entered the mainstream.

Full story -

[riddlerone] 05/12/2020 09:00

looks like 3 sets of rollovers to me

[tongosti] 04/12/2020 18:05

Gigantic volumes in play later in this afternoon - always an interesting thing to observe.

[btgman] 04/12/2020 15:56

Wouldn't want to be out of this next week. It will be very interesting to see where we are next Friday

AIMHO
GLA
BTG

[tongosti] 04/12/2020 10:55

Think longer term holders should be very happy if the share price stays within existing range. Price is stabilising and any fresh trading opportunity can only happen (for me anyways) around the edges of the range. Agnostic to either long or short for my next trade but in the meantime happy to sit on cash and avoid committing my copper coins to a lifeless stock.

[wan] 04/12/2020 07:20

I know I say this a lot - Testing has not, and will not stop anytime soon, as exemplified by what follows -

EKF flagged that it had expanded its PrimeStore MTM manufacturing capacity in the US with an additional production line at its Indiana facility, which complemented the existing manufacturing site in Boerne, Texas, the capacity of which was doubled. So, it's interesting that Longhorn's CSO chose this point to highlight the expansion (either the first bulk batch, or indeed a further expansion?)-

Longhorn Vaccines and Diagnostics expands bulk manufacturing of PrimeStore Molecular Transport Medium beyond the state of Texas and into Elkhart, Indiana (near Notre Dame). Dr. Luke T. Daum (second from left; blue gloves) works with Dr. Pritesh Shah, Michael Kuelbs and the EKF Life Science team in making an 800-Liter lot of PrimeStore in Indiana (EKF Life Sciences Division)

[malcolmmm] 03/12/2020 16:41

Any idea what they are worth

[malcolmmm] 03/12/2020 16:41

EKF Diagnostics has announced it wants to spin off its investment in Trellus Health Ltd (“Trellus̶1;) by issuing its Trellus shares to EKF Shareholders.

The value of the issue of Trellus shares has not been determined yet, neither has the distribution date or the number of Trellus shares that will be given to EKF Shareholders.

The Trellus shares will initially be in a ‘lock-in period’ where they will be held by trustees for the benefit of EKF Shareholders. The lock-in period is expected to be lifted in 2021 with the Trellus shares potentially listing on the AIM (Alternative Investment Market).

The spin off is subject to shareholder approval at a General Meeting to be held on 10 December 2020. If you would like to vote you can do so by logging into your account at www.hl.co.uk and clicking the dark blue icon next to your EKF shares. Any vote must be received before noon on Monday 7 December 2020.

Should you have any queries please contact us.

[rivaldo] 03/12/2020 12:37

Good spot re the FDA clearance on DiaSpect wan, cheers.

[wan] 03/12/2020 10:27

It is perhaps worthy of note that previous to the above clearance, Chris Mills described EKF as probably the worlds leading company testing haemoglobin (I appreciate he might be biased), and McKesson apparently has the largest market share in the US.

[wan] 03/12/2020 10:02

Food for thought - Cytiva has said that COVID-19 testing will remain key even as vaccines enter into the fray, and that they will continue to invest in diagnostic inventory and service labs.

Away from Covid-19 testing; In 2018 EKF's Diaspect TM was cleared for use at the point of care and Certificate of Waiver settings, and is sold through an exclusive private label distribution agreement with McKesson Medical-Surgical Inc, with Diaspect branded as the McKesson Consult™ Hb. That exclusive agreement gives McKesson exclusive rights for the distribution of DiaSpect Tm in all markets in the United States with the exception of blood banks.

I note that an FDA Decision Notice was issued on 24th November 2020 for clearance of EKF's Diaspect TM, which extends its use to blood banks in the US.

November 19, 2020
EKF-diagnostic GmbH
Attention: Ms. Karen Golomb
Ebendorfer Chaussee 3
Barleben, Germany 39179

Indications for Use:
The DiaSpect Tm system is intended for the in vitro quantitative measurement of total hemoglobin in non-anticoagulated capillary whole blood and venous whole blood drawn in K2-EDTA or lithium heparin tubes in point-of-care settings and in non-anticoagulated capillary whole blood and venous whole blood drawn in K2-EDTA tubes in blood bank settings. The DiaSpect Tm system consists of the DiaSpect Tm analyzer and specifically designed disposable cuvettes. The DiaSpect Tm analyzer is only to be used with DiaSpect Tm Cuvettes.


This obviously opens up a new additional, and potentially large, sales channel.

[buywell3] 03/12/2020 02:04

Good News


=========== Could it be as simple as a MEGADOSE of Vitamin C ? ============


Sepsis is associated with Covid-19 and many other viral infections

Sepsis and Septic Shock are now the BIGGEST killer in the world and growing even though many death certificates do not show sepsis as it occured whilst in the hospital and thus many legal cases result.


The use of MEGADOSES of vitamin C ( equivalent to thousands of oranges in a single treatment ) --- proved effective on animals with sepsis

So when a very sick man with sepsis caused by Covid-19 , suffering kidney failure and basically on his way out was given the Megadose of Vitamin C as used on animals --- low and behold it worked --- and a few weeks later he was out of Hospital when previously the doctors were expecting him to die.


IF this works on other cases of people with Sepsis or those going on mechanical ventilators --- very high risk --- then buywell thinks many businesses that are currently seeking a cure --- vaccine makers --- mass testing ---- could ALL LOSE BIGTIME

[tongosti] 02/12/2020 11:10

Last time I did Einstein you were on the opposite side of the fence and we both know who got the last laugh. Keep watching this space fella. There you go old chap.

[chris16041] 02/12/2020 11:06

Do I detect a touch of humility in your post Mr Market Please let us know when you feel it's worth investing her

Toodle pip old chap

[tongosti] 02/12/2020 10:20

For once I like this board in the sense that multiple bullish posts taking place every single morning are missing for a few days. Coupled with a bit of a more stable share price (still weak as it is vis-à-vis the larger market) is a not necessarily a bad thing. Sitting this all out at the moment - mainly due to the undetermined nature of Mr Market's price action - but watching v closely.

[speedsgh] 02/12/2020 07:29

Only a small initial order but positive all the same."In addition, initial purchase orders (of GBP16,500) have been placed with EKF Diagnostic Holdings plc ("EKF") for PrimeStore(R) MTM sample collection devices. Adam Reynolds is also a Director of EKF and this order has been treated as a related party transaction. Product pricing for the agreement has been prepared on an arm's-length basis and there is no minimum volume requirement."

[rivaldo] 02/12/2020 07:13

News of PrimeStore devices being used for Concepta's DNA testing service and its COVID-19 swab kit:

[tongosti] 30/11/2020 09:10

Mr Market up on the day with EKF buyers doing a Lord Lucan. I wonder why that is. As the wise man said - trading without stops is like driving without brakes. Conviction is the enemy of Truth!